Total Payments
$145,641
2024 Payments
$19,286
Companies
13
Transactions
78
Medicare Patients
818
Medicare Billing
$104,124
Payment Breakdown by Category
Consulting$57,735 (39.6%)
Travel$50,748 (34.8%)
Other$35,206 (24.2%)
Food & Beverage$1,952 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $57,735 | 14 | 39.6% |
| Travel and Lodging | $50,748 | 23 | 34.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $32,206 | 15 | 22.1% |
| Grant | $3,000 | 1 | 2.1% |
| Food and Beverage | $1,952 | 25 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pty Ltd | $31,488 | 7 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23,994 | 19 | $0 (2024) |
| Boehringer Ingelheim Pharma GmbH & Co.KG | $20,408 | 7 | $0 (2017) |
| Boehringer Ingelheim International GmbH | $17,791 | 17 | $0 (2024) |
| Boehringer Ingelheim RCV GmbH & Co KG | $15,419 | 4 | $0 (2019) |
| Boehringer Ingelheim (China) Investment Co., Ltd. | $12,932 | 5 | $0 (2017) |
| PFIZER INC. | $7,700 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $6,594 | 11 | $0 (2023) |
| Genentech, Inc. | $3,035 | 2 | $0 (2020) |
| Lupin Inc. | $2,655 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,286 | 13 | Boehringer Ingelheim Pharmaceuticals, Inc. ($8,921) |
| 2023 | $8,033 | 14 | Merck Sharp & Dohme LLC ($6,594) |
| 2022 | $3,591 | 2 | CSL Behring ($2,235) |
| 2021 | $6,815 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($4,160) |
| 2020 | $5,654 | 3 | Genentech, Inc. ($3,000) |
| 2019 | $51,365 | 22 | Boehringer Ingelheim Pty Ltd ($31,488) |
| 2018 | $17,522 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($9,933) |
| 2017 | $33,376 | 13 | Boehringer Ingelheim Pharma GmbH & Co.KG ($20,408) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,128.14 | General |
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $8,640.00 | General |
| 11/14/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $50.90 | General |
| 05/22/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $338.63 | General |
| Category: RESPIRATORY | ||||||
| 05/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $109.96 | General |
| 05/20/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $370.73 | General |
| Category: RESPIRATORY | ||||||
| 05/19/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Food and Beverage | In-kind items and services | $140.00 | General |
| Category: RESPIRATORY | ||||||
| 04/04/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $159.31 | General |
| Category: RESPIRATORY | ||||||
| 04/04/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $159.31 | General |
| Category: RESPIRATORY | ||||||
| 04/03/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $159.31 | General |
| Category: RESPIRATORY | ||||||
| 04/03/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $159.31 | General |
| Category: RESPIRATORY | ||||||
| 03/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $170.69 | General |
| Category: RESPIRATORY | ||||||
| 01/16/2024 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $7,700.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/20/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $5,115.00 | General |
| 11/20/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 09/18/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $200.70 | General |
| 09/18/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $64.97 | General |
| 09/18/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $59.57 | General |
| 09/18/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $51.85 | General |
| 09/17/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $250.70 | General |
| 09/17/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $249.00 | General |
| 09/17/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $133.90 | General |
| 09/17/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $29.79 | General |
| 09/16/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $288.25 | General |
| 09/12/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 192 | 241 | $78,398 | $26,213 |
| 2022 | 3 | 203 | 262 | $72,991 | $27,350 |
| 2021 | 3 | 210 | 280 | $72,255 | $29,527 |
| 2020 | 5 | 213 | 265 | $59,953 | $21,034 |
Total Patients
818
Total Services
1,048
Medicare Billing
$104,124
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 62 | $25,366 | $8,351 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 69 | $21,261 | $6,761 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 48 | 62 | $13,493 | $4,887 | 36.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 28 | 36 | $11,336 | $3,951 | 34.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $6,942 | $2,263 | 32.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 49 | $18,969 | $7,821 | 41.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 72 | 98 | $20,580 | $7,320 | 35.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 42 | 52 | $15,444 | $5,654 | 36.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 50 | $14,371 | $5,404 | 37.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 13 | $3,627 | $1,151 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 96 | 147 | $30,870 | $12,516 | 40.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 61 | 75 | $22,275 | $9,857 | 44.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 21 | 21 | $9,513 | $3,550 | 37.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 21 | $6,237 | $2,230 | 35.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 16 | $3,360 | $1,375 | 40.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 66 | 83 | $17,430 | $5,737 | 32.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 49 | 61 | $12,810 | $4,729 | 36.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 30 | 36 | $10,692 | $3,527 | 33.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 17 | 28 | $7,812 | $2,562 | 32.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 20 | 22 | $6,534 | $2,213 | 33.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 15 | 17 | $2,227 | $1,336 | 60.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 18 | $2,448 | $930.28 | 38.0% |
About Dr. Sonye Danoff, M.D
Dr. Sonye Danoff, M.D is a Pulmonary Disease healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720023534.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sonye Danoff, M.D has received a total of $145,641 in payments from pharmaceutical and medical device companies, with $19,286 received in 2024. These payments were reported across 78 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($57,735).
As a Medicare-enrolled provider, Danoff has provided services to 818 Medicare beneficiaries, totaling 1,048 services with total Medicare billing of $104,124. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Baltimore, MD
- Active Since 06/17/2006
- Last Updated 02/06/2013
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1720023534
Products in Payments
- OFEV (Drug) $110,022
- XELJANZ (Drug) $7,700
- Hizentra (Biological) $2,235
- Esbriet (Biological) $35.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Baltimore
Alan Schwartz, M.d, M.D
Pulmonary Disease — Payments: $1.2M
Pulmonary Disease $1.2M
Robert Wise, M.d, M.D
Pulmonary Disease — Payments: $653,703
Pulmonary Disease $653,703
Hitesh Batra, Md, MD
Pulmonary Disease — Payments: $504,969
Pulmonary Disease $504,969
Hans Lee, Md, MD
Pulmonary Disease — Payments: $421,517
Pulmonary Disease $421,517
Ko-Pen Wang
Pulmonary Disease — Payments: $416,486
Pulmonary Disease $416,486
Christian Merlo, M.d, M.D
Pulmonary Disease — Payments: $183,983
Pulmonary Disease $183,983